# Geo Group Inc: financial statements, quarterly

GEO · NYSE · CIK 923796 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/geo.md) · [Financials](/companies/geo/financials.md) · [Filings](/companies/geo/filings.md) · [Insiders](/companies/geo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/geo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [603](/filings/0000950170-24-125597.md) | [608 d](/filings/0001193125-26-071747.md) | [606](/filings/0000950170-25-065689.md) | [607](/filings/0000950170-25-104173.md) | [603](/filings/0001193125-25-269401.md) | [608 d](/filings/0001193125-26-071747.md) | [605](/filings/0001193125-26-211821.md) | [636](/filings/0001193125-26-337932.md) | [682](/filings/0001193125-25-269401.md) | [708 d](/filings/0001193125-26-071747.md) | [705](/filings/0001193125-26-211821.md) | [732](/filings/0001193125-26-337932.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [83.6](/filings/0000950170-24-125597.md) | [83.8 d](/filings/0001193125-26-071747.md) | [79.6](/filings/0000950170-25-065689.md) | [80.1](/filings/0000950170-25-104173.md) | [82.4](/filings/0001193125-25-269401.md) | [67.9 d](/filings/0001193125-26-071747.md) | [61.0](/filings/0001193125-26-211821.md) | [72.0](/filings/0001193125-26-337932.md) | [40.7](/filings/0001193125-25-269401.md) | [83.8 d](/filings/0001193125-26-071747.md) | [89.3](/filings/0001193125-26-211821.md) | [102](/filings/0001193125-26-337932.md) |
| Interest expense | $m | [55.8](/filings/0000950170-24-125597.md) | [53.2 d](/filings/0001193125-26-071747.md) | [51.3](/filings/0000950170-25-065689.md) | [50.6](/filings/0000950170-25-104173.md) | [45.5](/filings/0001193125-25-269401.md) | [43.2 d](/filings/0001193125-26-071747.md) | [42.4](/filings/0001193125-26-211821.md) | [41.9](/filings/0001193125-26-337932.md) | [38.2](/filings/0001193125-25-269401.md) | [37.9 d](/filings/0001193125-26-071747.md) | [38.3](/filings/0001193125-26-211821.md) | [38.6](/filings/0001193125-26-337932.md) |
| Income tax | $m | [6.5](/filings/0000950170-24-125597.md) | [5.4 d](/filings/0001193125-26-071747.md) | [8.1](/filings/0000950170-25-065689.md) | [(20.4)](/filings/0000950170-25-104173.md) | [11.7](/filings/0001193125-25-269401.md) | [10.0 d](/filings/0001193125-26-071747.md) | [1.8](/filings/0001193125-26-211821.md) | [10.6](/filings/0001193125-26-337932.md) | [56.4](/filings/0001193125-25-269401.md) | [16.9 d](/filings/0001193125-26-071747.md) | [15.0](/filings/0001193125-26-211821.md) | [18.9](/filings/0001193125-26-337932.md) |
| Net income | $m | [24.5](/filings/0000950170-24-125597.md) | [25.2 d](/filings/0001193125-26-071747.md) | [22.7](/filings/0000950170-25-065689.md) | [(32.5)](/filings/0000950170-25-104173.md) | [26.3](/filings/0001193125-25-269401.md) | [15.5 d](/filings/0001193125-26-071747.md) | [19.6](/filings/0001193125-26-211821.md) | [29.1](/filings/0001193125-26-337932.md) | [174](/filings/0001193125-25-269401.md) | [31.8 d](/filings/0001193125-26-071747.md) | [38.3](/filings/0001193125-26-211821.md) | [47.5](/filings/0001193125-26-337932.md) |
| Diluted EPS | $ per share | [0.16](/filings/0000950170-24-125597.md) | not reported | [0.14](/filings/0000950170-25-065689.md) | [(0.25)](/filings/0000950170-25-104173.md) | [0.19](/filings/0001193125-25-269401.md) | not reported | [0.14](/filings/0001193125-26-211821.md) | [0.21](/filings/0001193125-26-337932.md) | [1.24](/filings/0001193125-25-269401.md) | not reported | [0.29](/filings/0001193125-26-211821.md) | [0.36](/filings/0001193125-26-337932.md) |
| Basic EPS | $ per share | [0.17](/filings/0000950170-24-125597.md) | not reported | [0.15](/filings/0000950170-25-065689.md) | [(0.25)](/filings/0000950170-25-104173.md) | [0.19](/filings/0001193125-25-269401.md) | not reported | [0.14](/filings/0001193125-26-211821.md) | [0.21](/filings/0001193125-26-337932.md) | [1.26](/filings/0001193125-25-269401.md) | not reported | [0.29](/filings/0001193125-26-211821.md) | [0.36](/filings/0001193125-26-337932.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [141](/filings/0000950170-24-125597.md) | [94.0](/filings/0001193125-26-071747.md) | [126](/filings/0000950170-25-065689.md) | [46.3](/filings/0000950170-25-104173.md) | [70.6](/filings/0001193125-25-269401.md) | [76.9](/filings/0001193125-26-071747.md) | [64.8](/filings/0001193125-26-211821.md) | [67.9](/filings/0001193125-26-337932.md) | [184](/filings/0001193125-25-269401.md) | [69.0](/filings/0001193125-26-337932.md) | [80.2](/filings/0001193125-26-211821.md) | [55.0](/filings/0001193125-26-337932.md) |
| Current assets | $m | [539](/filings/0000950170-23-061074.md) | [529](/filings/0000950170-25-029972.md) | [531](/filings/0000950170-24-055810.md) | [490](/filings/0000950170-24-093922.md) | [484](/filings/0000950170-24-125597.md) | [500](/filings/0001193125-26-071747.md) | [503](/filings/0000950170-25-065689.md) | [504](/filings/0000950170-25-104173.md) | [685](/filings/0001193125-25-269401.md) | [719](/filings/0001193125-26-337932.md) | [699](/filings/0001193125-26-211821.md) | [635](/filings/0001193125-26-337932.md) |
| Total assets | $m | [3,724](/filings/0000950170-23-061074.md) | [3,696](/filings/0000950170-25-029972.md) | [3,685](/filings/0000950170-24-055810.md) | [3,644](/filings/0000950170-24-093922.md) | [3,633](/filings/0000950170-24-125597.md) | [3,632](/filings/0001193125-26-071747.md) | [3,632](/filings/0000950170-25-065689.md) | [3,661](/filings/0000950170-25-104173.md) | [3,809](/filings/0001193125-25-269401.md) | [3,844](/filings/0001193125-26-337932.md) | [3,812](/filings/0001193125-26-211821.md) | [3,742](/filings/0001193125-26-337932.md) |
| Current liabilities | $m | [433](/filings/0000950170-23-061074.md) | [437](/filings/0000950170-25-029972.md) | [421](/filings/0000950170-24-055810.md) | [389](/filings/0000950170-24-093922.md) | [442](/filings/0000950170-24-125597.md) | [340](/filings/0001193125-26-071747.md) | [389](/filings/0000950170-25-065689.md) | [561](/filings/0000950170-25-104173.md) | [423](/filings/0001193125-25-269401.md) | [357](/filings/0001193125-26-337932.md) | [398](/filings/0001193125-26-211821.md) | [384](/filings/0001193125-26-337932.md) |
| Long-term debt | $m | [1,789](/filings/0000950170-23-061074.md) | [1,726](/filings/0000950170-25-029972.md) | [1,717](/filings/0000950170-24-055810.md) | [1,739](/filings/0000950170-24-093922.md) | [1,639](/filings/0000950170-24-125597.md) | [1,711](/filings/0001193125-26-071747.md) | [1,658](/filings/0000950170-25-065689.md) | [1,475](/filings/0000950170-25-104173.md) | [1,553](/filings/0001193125-25-269401.md) | [1,649](/filings/0001193125-26-337932.md) | [1,589](/filings/0001193125-26-211821.md) | [1,512](/filings/0001193125-26-337932.md) |
| Current portion of debt | $m | not reported | [55.9](/filings/0000950170-25-029972.md) | not reported | not reported | not reported | [1.6](/filings/0000950170-25-029972.md) | not reported | not reported | not reported | [1.4](/filings/0001193125-26-071747.md) | not reported | not reported |
| Shareholders' equity | $m | [1,260](/filings/0000950170-23-061074.md) | [1,292](/filings/0000950170-25-029972.md) | [1,310](/filings/0000950170-24-055810.md) | [1,282](/filings/0000950170-24-093922.md) | [1,316](/filings/0000950170-24-125597.md) | [1,335](/filings/0001193125-26-071747.md) | [1,343](/filings/0000950170-25-065689.md) | [1,383](/filings/0000950170-25-104173.md) | [1,522](/filings/0001193125-25-269401.md) | [1,506](/filings/0001193125-26-337932.md) | [1,497](/filings/0001193125-26-211821.md) | [1,516](/filings/0001193125-26-337932.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [121 d](/filings/0000950170-24-125597.md) | [47.7 d](/filings/0001193125-26-071747.md) | [83.3](/filings/0000950170-25-065689.md) | [31.2 d](/filings/0000950170-25-104173.md) | [109 d](/filings/0001193125-25-269401.md) | [18.5 d](/filings/0001193125-26-071747.md) | [71.2](/filings/0001193125-26-211821.md) | [39.2 d](/filings/0001193125-26-337932.md) | [79.6 d](/filings/0001193125-25-269401.md) | [(117) d](/filings/0001193125-26-071747.md) | [156](/filings/0001193125-26-211821.md) | [80.0 d](/filings/0001193125-26-337932.md) |
| Capital expenditure | $m | [22.0 d](/filings/0000950170-24-125597.md) | [19.4 d](/filings/0001193125-26-071747.md) | [14.8](/filings/0000950170-25-065689.md) | [24.4 d](/filings/0000950170-25-104173.md) | [18.7 d](/filings/0001193125-25-269401.md) | [20.8 d](/filings/0001193125-26-071747.md) | [30.8](/filings/0001193125-26-211821.md) | [36.8 d](/filings/0001193125-26-337932.md) | [93.7 d](/filings/0001193125-25-269401.md) | [36.2 d](/filings/0001193125-26-071747.md) | [21.7](/filings/0001193125-26-211821.md) | [20.6 d](/filings/0001193125-26-337932.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001193125-26-211821.md) | [0.0 d](/filings/0001193125-26-337932.md) | [41.6 d](/filings/0001193125-25-269401.md) | [49.4 d](/filings/0001193125-26-071747.md) | [50.1](/filings/0001193125-26-211821.md) | [36.6 d](/filings/0001193125-26-337932.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [122](/filings/0000950170-23-061074.md) | [125](/filings/0000950170-24-055810.md) | [123](/filings/0000950170-24-093922.md) | [123](/filings/0000950170-24-125597.md) | [131](/filings/0000950170-25-065689.md) | [131](/filings/0000950170-25-104173.md) | [138](/filings/0001193125-25-269401.md) | [141](/filings/0001193125-26-211821.md) | [140](/filings/0001193125-26-337932.md) | [140](/filings/0001193125-25-269401.md) | [134](/filings/0001193125-26-211821.md) | [132](/filings/0001193125-26-337932.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 131,619,584 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-337932.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.